Literature DB >> 17001227

Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology.

Ian M Graham1, Murray Stewart, Michaël G L Hertog.   

Abstract

BACKGROUND: Cardiovascular disease mortality remains high in Europe and many patients have elevated risk factors, despite evidence-based targets and treatment guidelines. This survey examined barriers to implementing cardiovascular risk reduction guidelines.
DESIGN: We conducted a semi-structured market research survey of physicians.
METHODS: The survey was conducted in six European countries among cardiologists and primary care physicians. In total, 67 questions were used: 35 had multiple choice answers (prompted) and 32 allowed any answer (unprompted). Respondents were working full-time in patient care (>or=3 years experience) and were in a position to initiate cardiovascular drug treatment.
RESULTS: Of the 220 respondents (155 primary care physicians, 65 cardiologists), most (85%) based assessment of cardiovascular risk on all risk factors, reflecting a global approach to risk, rather than considering risk factors individually. A majority (62%) used subjective assessments for establishing global risk rather than guidelines or risk calculators. The most common unprompted barrier to guideline implementation was patient compliance (36%) and a lack of time (23%), and when prompted, the most important was government health policy (40%). The most common unprompted suggestion for improving implementation were financial opportunities (24%) and clear and easy to use guidelines (23%), while when prompted the most important change required was the development of simpler guidelines (46%).
CONCLUSIONS: Although a majority of physicians are aware of the need to look at a combination of cardiovascular disease risk factors, less than half use guidelines or risk calculators to determine total risk. It is recommended that guidelines need to be simpler and easier to use and supplemented with (patient friendly) risk calculators.

Entities:  

Mesh:

Year:  2006        PMID: 17001227     DOI: 10.1097/01.hjr.0000219112.02544.24

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  35 in total

Review 1.  Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.

Authors:  J D Schwalm; Martin McKee; Mark D Huffman; Salim Yusuf
Journal:  Circulation       Date:  2016-02-23       Impact factor: 29.690

Review 2.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

3.  Practice adaptive reserve and colorectal cancer screening best practices at community health center clinics in 7 states.

Authors:  Shin-Ping Tu; Vicki M Young; Letoynia J Coombs; Rebecca S Williams; Michelle C Kegler; Amanda T Kimura; Betsy C Risendal; Daniela B Friedman; Beth A Glenn; Debbie J Pfeiffer; Maria E Fernandez
Journal:  Cancer       Date:  2014-12-18       Impact factor: 6.860

Review 4.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

5.  Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them.

Authors:  Su May Liew; Claire Blacklock; Jenny Hislop; Paul Glasziou; David Mant
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

6.  Applying systems engineering to implement an evidence-based intervention at a community health center.

Authors:  Shin-Ping Tu; Sherry Feng; Richard Storch; Mei-Po Yip; HeeYon Sohng; Mingang Fu; Alan Chun
Journal:  J Health Care Poor Underserved       Date:  2012-11

Review 7.  A systematic review of the effectiveness of knowledge translation interventions for chronic noncancer pain management.

Authors:  Maria B Ospina; Paul Taenzer; Saifee Rashiq; Joy C MacDermid; Eloise Carr; Dagmara Chojecki; Christa Harstall; James L Henry
Journal:  Pain Res Manag       Date:  2013 Nov-Dec       Impact factor: 3.037

8.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12

9.  Atherosclerosis: from biology to pharmacological treatment.

Authors:  Graziano Riccioni; Valeriana Sblendorio
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

10.  Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia.

Authors:  Dugee Otgontuya; Sophal Oum; Brian S Buckley; Ruth Bonita
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.